Gray, Richard and McConkey, Christopher C. (2008) Adjuvant chemotherapy for rectal cancer – Authors' reply. Lancet, Vol.371 (No.9623). p. 1503. doi:10.1016/S0140-6736(08)60651-0

Research output not available from this repository, contact author.

Request Changes to record.

Abstract

We agree with Krzysztof and Magdalena Bujko that a meta-analysis of individual patients' data is needed to resolve whether adjuvant chemotherapy produces worthwhile benefits in patients with rectal cancer who receive preoperative or postoperative radiotherapy.
The QUASAR study does, however, provide no reason to believe that chemotherapy is any more or less effective among patients who also receive radiotherapy.

Item Type:	Journal Item
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RM Therapeutics. Pharmacology
Divisions:	Faculty of Medicine > Warwick Medical School > Health Sciences Faculty of Medicine > Warwick Medical School
Library of Congress Subject Headings (LCSH):	Rectum -- Cancer, Cancer -- Adjuvant treatment -- Analysis, Chemotherapy -- Analysis
Journal or Publication Title:	Lancet
Publisher:	The Lancet Publishing Group
ISSN:	0140-6736
Official Date:	3 May 2008
Dates:	Date Event 3 May 2008 Published
Volume:	Vol.371
Number:	No.9623
Page Range:	p. 1503
DOI:	10.1016/S0140-6736(08)60651-0
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Restricted or Subscription Access
Version or Related Resource:	Reply to Bujko, K. and Bujko, M. (2008). Adjuvant chemotherapy for rectal cancer. The Lancet, 371(9623), pp. 1502-1503.
Related URLs:	Other

Request changes or add full text files to a record

Repository staff actions (login required)

View Item